After six chemotherapy treatments for bowel cancer and all indicators are normalized, a five-year survival rate of about 50% to 90% can be achieved, and the exact duration of survival can vary.
Bowel cancer is a common malignant tumor, with colon cancer and rectal cancer being the most common, mostly caused by heredity, gene mutation and other factors. Chemotherapy is one of the important treatments, and six times of chemotherapy is mostly used as postoperative adjuvant treatment, and more commonly used in patients with stage I~III. After the completion of chemotherapy, the specific five-year survival rate of patients is more related to the stage.
Among them, stage I patients can get about 90% five-year survival rate; stage II about 60%~70%; stage III about 50%. For bowel cancer commonly used chemotherapeutic drugs include fluorouracil, capecitabine, etc., which need to be applied under the guidance of doctors.
Bowel cancer patients also need regular review after chemotherapy in order to find out the problems in time and treat them actively to prolong the survival period and improve the prognosis.